Research and development into new, groundbreaking medicines is critical to the healthcare system, and often associated with the high cost of prescriptions. But when it comes to innovation in the pharmaceutical industry, new drugs are only part of the story.
On Oct. 25, a panel of top executives from Astellas, Takeda, and Horizon will discuss initiatives at their companies to try to improve the lives of patients that go beyond medicine. Technology and analytics are changing the industry, as are partnerships with small startups and academia.
Join us for this dynamic discussion about the future of innovation in pharma.